Phibro Animal Health Corporation PAHC
35.15 USD +0.51 (+1.47%)
At closeNov 11, 2026, 4:00 PM EST
35.15 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
34.28 Day range 35.30
28.25 52-week range 60.08
- YTD
- -5.92%
- 1 year
- -22.46%
News
seekingalpha.com Phibro Animal Health Corporation (PAHC) Q1 2027 Earnings Call Transcript Phibro Animal Health Corporation ( PAHC ) Q1 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Patrick Rodriguez - Vice President of Finance &…
benzinga.com Phibro Animal Health Q1 2027 Earnings Call Transcript Phibro Animal Health (NASDAQ:PAHC) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Phibro Animal Health Affirms FY2027 Adj EPS Guidance of $3.41-$3.59 vs $3.50 Est; Affirms FY2027 Sales Guidance of $1.550B-$1.600B vs $1.578B Est Phibro Animal Health (NASDAQ:PAHC) affirms FY2027 Adj EPS guidance from $3.41-$3.59 to $3.41-$3.59 vs $3.50 analyst estimate. Affirms FY2027 sales outlook from $1.550 billion-$1.600 billion to $1.550…
benzinga.com Phibro Animal Health Q4 2026 Earnings Call: Complete Transcript Phibro Animal Health (NASDAQ:PAHC) held its fourth-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs.…- benzinga.com Phibro Animal Health Corp To Close Chicago Heights Facility In Summer 2027, Affecting About 100 Employees MFA SITE CLOSUREThrough the MFA acquisition in 2024, Phibro added several manufacturing facilities. Since then, we have conducted a comprehensive review of our manufacturing network to ensure our…
benzinga.com Phibro Animal Health Sees FY2027 Adj EPS $3.41-$3.59 vs $3.34 Est; Sees Sales $1.550B-$1.600B vs $1.548B Est Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 Adj EPS of $3.41-$3.59 vs $3.34 analyst estimate. sees sales of $1.550 billion-$1.600 billion vs $1.548 billion analyst estimate.
benzinga.com Phibro Animal Health Appoints Daniel (Dani) Bendheim As CEO And President Effective July 1, 2026 https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069899/000110465926078323/tm2619111d1_8k.htm- benzinga.com Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44 Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $62 to $44.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below. Year-over-year percentages are calculated using the midpoint of the guidance ranges.Net sales of…- benzinga.com Phibro Animal Health Corporation Announces Expected Implementation Of New Regulatory Framework Governing The Use Of Certain Antimicrobials In Brazil The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed…
- benzinga.com Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62 Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.
benzinga.com Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday 
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket 
benzinga.com Phibro Animal Health Raises FY2026 GAAP EPS Guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 analyst estimate..- benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 Est; Raises FY2026 Sales Guidance from $1.430B-$1.480B to $1.450B-$1.500B vs $1.466B Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.450…
benzinga.com Phibro Animal Health Earnings Review: Q2 Summary - benzinga.com Phibro Animal Health Q2 Adj. EPS $0.87 Beats $0.67 Estimate, Sales $373.900M Beat $355.637M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 58.18 percent increase over earnings…
- benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com Earnings Preview For Phibro Animal Health 
benzinga.com JP Morgan Maintains Overweight on Phibro Animal Health, Raises Price Target to $50 JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overweight and raises the price target from $45 to $50.- benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 Est; Affirms FY2026 Sales Guidance of $1.430B-$1.480B vs $1.459B Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 analyst estimate. Affirms FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.430…
benzinga.com Phibro Animal Health Q1 Adj. EPS $0.73 Beats $0.62 Estimate, Sales $363.900M Beat $346.957M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.62 by 17.17 percent. This is a 108.57 percent increase over earnings…
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com A Preview Of Phibro Animal Health's Earnings - benzinga.com Phibro Animal Health To Develop, Commercialize Lighthouse Pharma's Proprietary Compound For Canine Periodontal Care Under Signed Licensing Agreement TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ:PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with…
benzinga.com B of A Securities Maintains Underperform on Phibro Animal Health, Raises Price Target to $27 B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the price target from $19 to $27.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday 
benzinga.com Stock Market Today: Nvidia Drags Down Nasdaq Futures, Dow Trades Higher—Dollar General, Dell, Best Buy In Focus (UPDATED) U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket 
benzinga.com Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.- benzinga.com Phibro Animal Health Sees FY2026 Adj EPS $2.52-$2.70 vs $2.03 Est; Sees Sales $1.430B-$1.480B vs $1.278B Est Phibro Animal Health (NASDAQ:PAHC) is looking for FY2026 Adj EPS of $2.52-$2.70 vs $2.03 analyst estimate. sees sales of $1.430 billion-$1.480 billion vs $1.278 billion analyst estimate.
- benzinga.com Phibro Animal Health Q4 EPS $0.57 Beats $0.52 Estimate, Sales $378.70M Beat $361.80M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.52 by 9.62 percent. This is a 39.02 percent increase over earnings of…
- benzinga.com Earnings Scheduled For August 27, 2025
- benzinga.com A Look Ahead: Phibro Animal Health's Earnings Forecast
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
benzinga.com U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday 
benzinga.com Top 2 Health Care Stocks That May Plunge This Month 
benzinga.com This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - benzinga.com JP Morgan Upgrades Phibro Animal Health to Overweight, Raises Price Target to $35 JP Morgan analyst Ekaterina Knyazkova upgrades Phibro Animal Health (NASDAQ:PAHC) from Neutral to Overweight and raises the price target from $25 to $35.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $26 Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $21 to $26.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $21 Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $20 to $21.
- benzinga.com Phibro Animal Health Raises FY2025 GAAP EPS Guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 Est Phibro Animal Health (NASDAQ:PAHC) raises FY2025 GAAP EPS guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 analyst estimate..
- benzinga.com Phibro Animal Health Raises FY2025 Adj EPS Guidance from $1.87-$2.01 to $1.96-$2.09 vs $1.94 Est; Narrows FY2025 Sales Guidance from $1.25B-$1.30B to $1.26B-$1.29B vs $1.28B Est Phibro Animal Health (NASDAQ:PAHC) raises FY2025 Adj EPS guidance from $1.87-$2.01 to $1.96-$2.09 vs $1.94 analyst estimate. Narrows FY2025 sales outlook from $1.25 billion-$1.30 billion to $1.26…
- benzinga.com Phibro Animal Health Q3 Adj. EPS $0.63 Beats $0.52 Estimate, Sales $347.80M Miss $352.40M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.52 by 21.15 percent. This is a 103.23 percent increase over earnings…
- benzinga.com Earnings Scheduled For May 7, 2025